Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05377892 · ClinicalTrials.gov registry record · NA
The Impact of Dietary Protein on the Metabolome
A NA study, sponsored by Stony Brook University.
- Completed
- Registry status
- NA
- Development phase
- 9
- Enrollment target
NCT05377892: Completed NA study, sponsored by Stony Brook University.
NCT05377892 is a NA study that has completed, run by Stony Brook University. The registered enrollment target is 9 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05377892, a NA study, has completed, sponsored by Stony Brook University.
- COMPLETED
- Registry status
- NA
- Development phase
- 9 participants
- Enrollment target
Study Summary
It is known that tumors have an affinity for taking up amino acids from circulation or nearby tissues to use as a fuel source, to enhance their growth. Work in rodents has shown that when the levels of amino acids are reduced in diet, tumor growth is slowed and tumors are more susceptible to anti-cancer therapies. There are limited evidence-based dietary recommendations for cancer patients, which represents an urgent and unmet need. It is likely that reducing dietary protein will be beneficial, however this has not been tested. In advance of carrying out a study in cancer patients a study in healthy volunteers needs to be conducted to determine whether altering the amount of dietary protein, impacts the levels of amino acids (or other metabolites) in blood or the intestine. By demonstrating that altering dietary protein can alter the metabolome of healthy individuals, it will provide the information needed to reduce protein intake in cancer patients in future studies.
Primary Outcome
Participants will take a picture of each meal before and after eating and upload the pictures via a Qualtrics-based survey. The investigators will use these images to estimate how much food has been eaten at each meal, then calculate macronutrient intake based on the nutrient content of each food item. Participants will log any consumption of food or beverages not provided for the study via this same Qualtrics-based survey in order to estimate the contribution of non-study foods to overall macro
Interventions
- OTHER Dietary protein
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 9 participants |
| Start Date | 2019-11-04 |
| Est. Completion | 2020-03-05 |
| Phase | NA |
What the finished NCT05377892 record still lists
NCT05377892 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 9 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 1 intervention - of which Dietary protein is the first listed.
NCT05377892 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05377892 about?
NCT05377892 is a clinical study titled "The Impact of Dietary Protein on the Metabolome". It is known that tumors have an affinity for taking up amino acids from circulation or nearby tissues to use as a fuel source, to enhance their growth. Work in rodents has shown that when the levels of amino acids are reduced in diet, tumor growth is slowed and tumors are more susceptible to anti-ca...
What is the current status of trial NCT05377892?
This trial is currently completed. It is a NA study. The enrollment target is 9 participants. The study started on 2019-11-04. Estimated completion is 2020-03-05.
What interventions are being tested in trial NCT05377892?
The interventions under investigation include: Dietary protein (OTHER).
Who is sponsoring clinical trial NCT05377892?
This trial is sponsored by Stony Brook University, which has 127 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05377892's enrollment target sits among peer trials
9 1975th of 2000 higher than 25 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI